Tuesday, March 06, 2012 3:46:31 PM
March 6, 2012, 3:12 p.m. EST
By Val Brickates Kennedy
BOSTON (MarketWatch) -- Shares of DUSA Pharmaceuticals /quotes/zigman/54163/quotes/nls/dusa DUSA +21.72% soared 20% to $5.62 Tuesday after the company reported a higher quarterly profit. Analysts at C.K. Cooper initiated coverage of the stock with a buy rating, while Roth Capital analyst Scott Henry raised his price target for the stock to $7 a share.
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM